α-1 microglobulin

α-1 microglobulin (A1M) is a ubiquitously expressed plasma and tissue protein that exhibits reductase, radical-binding, and heme-binding activities^[1]. Mechanistically, A1M participates in detoxifying heme and reactive oxygen species, thereby protecting red blood cells (RBCs) from hemolysis induced by oxidative stress or osmotic challenges^[1][2]. The protein is encoded by the α1-microglobulin-bikunin precursor (AMBP) gene, which also produces the proteinase inhibitor bikunin, and is primarily synthesized in the liver^[1]. Functionally, A1M is required for proper bikunin folding, as deficiency of A1M leads to misfolding or aggregation of bikunin^[1]. In addition to its cytoprotective role, A1M binds heparin both in vitro and in vivo, suggesting a potential application for plasma purification and biotechnological manipulation^[1]. In disease models, A1M mitigates oxidative damage in conditions associated with extracellular hemoglobin, including hemolytic anemias, pre-eclampsia, cerebral intraventricular hemorrhage, chronic inflammatory ulcers, and hemoglobin-based oxygen carrier infusion^[2]. Compared with other plasma antioxidants, A1M provides targeted protection against heme-mediated radical formation, highlighting its isoform-specific relevance^[2]. Experimental applications have leveraged A1M’s radical-scavenging activity, particularly in oxidative stress and hemolysis studies, underscoring its value as a model protein for redox biology research^[1][2].